XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2021 $ 235,155 $ 4 $ 424,492   $ (189,341)
Balance, shares at Dec. 31, 2021   38,943,110      
Issuance of common stock upon exercise of stock options 349   349    
Issuance of common stock upon exercise of stock options, shares   142,391      
Vesting of early exercised stock options 6   6    
Vesting of early exercised stock options, shares   4,311      
Stock-based compensation 3,279   3,279    
Net loss (32,066)       (32,066)
Ending Balance at Mar. 31, 2022 206,723 $ 4 428,126   (221,407)
Balance, shares at Mar. 31, 2022   39,089,812      
Beginning Balance at Dec. 31, 2022 $ 675,968 $ 5 1,007,485 $ (429) (331,093)
Balance, shares at Dec. 31, 2022 46,841,661 46,841,661      
Issuance of common stock upon exercise of stock options $ 2,929   2,929    
Issuance of common stock upon exercise of stock options, shares 387,387 387,387      
Issuance of common stock in public offerings, net of issuance costs $ 50,012   50,012    
Issuance of common stock in public offerings, net of issuance costs, shares   483,256      
Vesting of early exercised stock options 5   5    
Vesting of early exercised stock options, shares   1,874      
Stock-based compensation 9,382   9,382    
Unrealized gain on marketable securities 197     197  
Net loss (40,876)       (40,876)
Ending Balance at Mar. 31, 2023 $ 697,617 $ 5 $ 1,069,813 $ (232) $ (371,969)
Balance, shares at Mar. 31, 2023 47,714,178 47,714,178